BPA Call 36C24126A0031-36C24126N0536
- Not listed
- This federal contract award to Diasorin Molecular, LLC, a foreign-owned manufacturer of medical diagnostic products, is for the provision of herpes and cytomegalovirus (CMV) testing reagents to the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 1. The $51,087.39 firm-fixed-price Blanket Purchase Agreement (BPA) has an ultimate completion date of April 30, 2023. It was awarded on November 16, 2022 without any set-aside designation. The contract involves call...
- This federal contract award is for the provision of herpes and cytomegalovirus (CMV) testing reagents by Diasorin Molecular, LLC, a foreign-owned, for-profit medical diagnostic manufacturer, to the U.S. Department of Veterans Affairs (VA). The contract is a $997,200 Blanket Purchase Agreement (BPA) issued by the VA's Veterans Integrated Service Network 1 (VISN 1), with a period of performance through April 30, 2026. The contract does not have a set-aside designation, reflecting Diasorin...
- This federal contract award to Diasorin Molecular, LLC, a foreign-owned, for-profit manufacturer of medical diagnostic products and testing equipment, was made by the U.S. Department of Veterans Affairs (VA) through Veterans Integrated Service Network (VISN) 23. The $169,000.00 Firm Fixed Price delivery order contract, which does not have a set-aside designation, is for the provision of COVID-19 tests and analyzers to support the VA's pandemic response and ongoing infectious disease testing...
- This is a firm-fixed-price contract awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 1 to Diasorin Molecular, LLC, a foreign-owned, for-profit manufacturer of medical diagnostic products and testing equipment. The $108,877.03 contract is for the delivery of herpes and cytomegalovirus (CMV) testing reagents to support VA healthcare facilities within VISN 1. The contract is a Blanket Purchase Agreement (BPA) with a period of performance through April 2026....
- Diasorin Molecular LLC was awarded a firm fixed price blanket purchase agreement (BPA) call contract by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1. The contract is valued at up to $75,908.20 to provide herpes/cytomegalovirus (CMV) testing reagents to support laboratory diagnostic services. The contract has a period of performance through April 30, 2026 and was awarded on May 1, 2021. No set-aside designation was applied. The testing...
- This federal contract award to Diasorin Inc., a foreign-owned for-profit company, is for reagents and consumables to support Herpes and Cytomegalovirus PCR testing. The $161,200 firm fixed price delivery order was issued by the Department of Veterans Affairs' Veterans Integrated Service Network 1. No set-aside designation was used for this acquisition. Diasorin has numerous indefinite delivery contracts and schedule agreements with the VA, Department of Defense, and other federal agencies to...
- The U.S. Department of Veterans Affairs (VA) awarded a Delivery Order contract worth $28,316.49 to Diasorin Molecular, LLC, a foreign-owned, for-profit manufacturer of medical diagnostic products and testing equipment. The contract is to provide COVID-19 tests and analyzers to support the VA's pandemic response efforts across its Veterans Integrated Service Network (VISN) 23. Diasorin Molecular has previously been awarded several Indefinite Delivery Vehicle (IDV) contracts by the VA to supply...
- This contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Diasorin Molecular LLC, a for-profit manufacturer of medical diagnostic products and testing equipment. The $225,508.09 firm-fixed price purchase order is for the provision of DiaSorin reagents and consumables to support infectious disease testing and surveillance at VA medical facilities. The contract was awarded without any set-aside designation. Through this and other VA contracts,...
- The Department of Veterans Affairs (VA) awarded a firm fixed-price delivery order contract to Diasorin Inc., a foreign-owned for-profit medical diagnostics company, to provide reagents and consumables for herpes and cytomegalovirus PCR testing. The $155,445.16 contract supports the VA's Veterans Health Administration and Veterans Integrated Service Network 1 in Stillwater, Minnesota. Diasorin has a history of providing diagnostic testing equipment, reagents, and services to the VA, Department of...
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded a delivery order to Diasorin Molecular, LLC, a foreign-owned for-profit manufacturer of medical diagnostic products and testing equipment, to provide COVID-19 test kits. The firm-fixed-price contract, valued at $159,143.26, was issued under a VA Veterans Integrated Service Network 23 (VISN 23) contract vehicle without any set-aside designation. Diasorin Molecular has previously provided COVID-19, influenza,...
- 36C24126A0031Blanket Purchase Agreement
- 36C24126A0031-36C24126N0536BPA Call
Diasorin Molecular, LLC received a $149.9K blanket purchase agreement (BPA) call for herpes virology and histology testing reagents and supplies from Veterans Integrated Service Network (VISN) 1, a civilian division of the Department of Veterans Affairs. The contract, awarded on May 1, 2026, is structured as a firm fixed-price BPA call with performance extending through April 30, 2027, and will be performed at the VA facility in West Haven, Connecticut. No set-aside designation was applied to this award, reflecting the contractor's specialized proprietary diagnostic technologies and established capability to meet federal requirements for infectious disease testing. This BPA call is issued under Diasorin Molecular's existing single-award Blanket Purchase Agreement with VA VISN 1 valued at $997.2K for herpes and cytomegalovirus testing reagents, which has generated multiple task orders supporting laboratory diagnostic services across VISN 1 medical centers and clinics. Diasorin Molecular, a foreign-owned manufacturer of molecular diagnostic products headquartered in Cypress, California, has established itself as a key supplier to VA healthcare systems, with an active portfolio of contracts and indefinite delivery vehicles totaling approximately $11.3 million through 2030, enabling the delivery of critical diagnostic capabilities including COVID-19 tests, herpes and cytomegalovirus reagents, and emerging pathogen screening solutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $149.9k | 4/29/26 |